Clorox (NYSE:CLX) Stock Price Target Raised at UBS Group

Clorox (NYSE:CLX) had its target price lifted by stock analysts at UBS Group from $91.00 to $96.00 in a research note issued on Tuesday, Benzinga reports. The firm presently has a “neutral” rating on the stock. UBS Group‘s target price would indicate a potential upside of 3.65% from the stock’s previous close.

Several other brokerages have also recently issued reports on CLX. Weiss Ratings reissued a “hold (c-)” rating on shares of Clorox in a research note on Tuesday, October 6th. BNP Paribas Exane reduced their target price on shares of Clorox from $97.00 to $95.00 and set a “neutral” rating for the company in a research note on Monday, July 20th. Jefferies Financial Group cut shares of Clorox from a “buy” rating to a “hold” rating and cut their price target for the stock from $125.00 to $98.00 in a report on Tuesday, July 28th. Morgan Stanley dropped their price objective on Clorox from $97.00 to $87.00 and set an “equal weight” rating on the stock in a report on Thursday, October 15th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of Clorox in a report on Tuesday. One research analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and four have given a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Reduce” and a consensus target price of $93.64.

Clorox Stock Performance

CLX stock traded up $2.72 during trading on Tuesday, hitting $92.62. The company had a trading volume of 1,098,582 shares, compared to its average volume of 2,642,461. The firm has a 50-day moving average price of $88.27 and a 200-day moving average price of $99.92. Clorox has a 1-year low of $79.12 and a 1-year high of $128.90. The firm has a market cap of $11.20 billion, a PE ratio of 19.18, a price-to-earnings-growth ratio of 2.91 and a beta of 0.59. The company has a quick ratio of 0.38, a current ratio of 0.66 and a debt-to-equity ratio of 15.80.

Clorox (NYSE:CLX) last released its earnings results on Monday, November 2nd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.07 by $0.48. Clorox had a return on equity of 522.23% and a net margin of 8.74%. The business had revenue of $1.91 billion for the quarter, compared to analyst estimates of $1.88 billion. During the same quarter in the previous year, the company posted $0.85 earnings per share. The company’s revenue for the quarter was up 33.3% compared to the same quarter last year. On average, analysts expect that Clorox will post 5.66 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CLX. Geneos Wealth Management Inc. boosted its holdings in Clorox by 9.3% in the first quarter. Geneos Wealth Management Inc. now owns 1,402 shares of the company’s stock valued at $145,000 after purchasing an additional 119 shares during the last quarter. Elevation Wealth Partners LLC boosted its stake in shares of Clorox by 32.3% during the 3rd quarter. Elevation Wealth Partners LLC now owns 565 shares of the company’s stock valued at $46,000 after buying an additional 138 shares during the last quarter. Root Financial Partners LLC boosted its stake in shares of Clorox by 83.8% during the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock valued at $33,000 after buying an additional 145 shares during the last quarter. Eastern Bank grew its position in shares of Clorox by 3.1% during the third quarter. Eastern Bank now owns 5,052 shares of the company’s stock worth $409,000 after buying an additional 150 shares in the last quarter. Finally, Mystic Asset Management Inc. grew its position in shares of Clorox by 1.3% during the third quarter. Mystic Asset Management Inc. now owns 12,112 shares of the company’s stock worth $981,000 after buying an additional 153 shares in the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

More Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Quarterly results exceeded expectations. Clorox reported adjusted earnings of $1.55 per share, well above the $1.07 consensus estimate, while revenue rose 33.3% year over year to $1.91 billion, topping the $1.88 billion forecast. Clorox Surpasses Q1 Earnings and Revenue Estimates
• Positive Sentiment: Margin recovery efforts are showing progress. Productivity gains, strategic pricing and anticipated savings from the GOJO integration are helping offset higher input costs, supporting management’s confidence in its recovery plans. Productivity Gains and Strategic Pricing Drive Margin Recovery
• Positive Sentiment: Analyst sentiment improved. Evercore ISI upgraded Clorox from “underperform” to “in line” with a $99 price target, citing the new CEO’s turnaround experience and potential for earnings recovery. Evercore ISI Upgrades Clorox
• Neutral Sentiment: Fiscal 2027 guidance was maintained. Clorox forecasts adjusted EPS of $5.70-$6.00 and revenue of $7.6 billion-$7.7 billion, broadly in line with analyst expectations. Clorox Reports Fiscal 2027 Results
• Negative Sentiment: Cost inflation remains a key risk. Management expects rising input costs and margin pressures to push results toward the lower end of its EPS range, increasing the importance of pricing actions, productivity savings and the GOJO integration. Clorox Earnings Call Highlights Inflation and Margin Pressures

Clorox Company Profile

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.